Irwin Naturals Revenue Sluggish In Q2, Net Loss Grows YOY
Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) reported its financial results for the second quarter of fiscal 2023, the period ended June 30, revealing a slight year-over-year improvement in revenue - up by 1.5% to $22.1 million.
Irwin Naturals Q1 FY23 Revenue Stagnates, What About Adjusted EBITDA?
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA: 97X) released its financial results for the first quarter and year ended March 31, 2023, revealing revenue of $22.5 million, down 0.4% from $22.6 million in Q1 2022.
Irwin Naturals FY22 Revenue Declines 10.8%, What About Adjusted EBITDA?
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) revenue in 2022 was $89.5 million, down 10.8% from $100.3 million in 2021.
Cannabis Scandal And Resignation Of Oregon Official, USCC’s New Leadership & More Executive Moves
New Team Of Top Executives And Experts To Lead USCC Amid Possible Cannabis Policy Reform
Irwin Naturals Cannabis Products Launch Nationwide In Canada
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) announced the release of Irwin Naturals Cannabis’ new CBD 25mg Softgels in Canada, available nationwide through the Starseed Medicinal Medical Group platform.
Irwin Naturals Acquires Ketamine Clinic In Kentucky Adding $3M In Projected EBITDA
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) has successfully completed the acquisition of Serenity Health, LLC, a ketamine clinic in Louisville, KY. The agreement with Serenity was initially announced November 30, 2022.
Irwin Naturals TCH Products To Hit The Shelves Of ~2700 Dispensaries In Oklahoma Via Gold Rush
Irwin Naturals Inc. (OTCQB: IWINF) (CSE:IWIN) (FRA:97X) entered into a licensing agreement with a partner in Oklahoma to produce and distribute Irwin Naturals THC products.